Atlas Trials

Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy

Clinical trial NCT05991336 · RECRUITING

Trial details

NCT number
NCT05991336
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
RECRUITING
Study type
OBSERVATIONAL
Transfusion-dependent Beta-ThalassemiaGene Therapy
Start date
2023-06-05
Primary completion
2028-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.